Organon & Co reports results for the quarter ended December 31 - Earnings Summary

Organon & Co.

13/02/2025 14:31

* Organon & Co  OGN.N  reported quarterly adjusted earnings
of 90
cents​​ per share for the quarter ended December 31, higher than
the same quarter last year, when the company reported EPS of 88
cents.  The mean expectation of eight analysts for the quarter
was for earnings of 87 cents per share. Wall Street expected
results to range from 82 cents to 93 cents per share.
    * Revenue fell 0.4% to $1.59 billion from a year ago;
analysts
expected $1.59 billion. 
    * Organon & Co's reported EPS for the quarter was 42 cents​.
    * The company reported quarterly net income of $109 million.
    * Organon & Co shares had fallen by 1.5% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 6.3%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and 2 "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "hold"

Wall Street's median 12-month price target for Organon & Co is
$20.00 
This summary was machine generated from LSEG data February 13 at
02:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      0.87           0.90           Beat
 Sep. 30 2024      0.90           0.87           Missed
 Jun. 30 2024      1.08           1.12           Beat
 Mar. 31 2024      0.97           1.22           Beat